Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C21H24N2O2.ClH |
| Molecular Weight | 372.888 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CC[C@@]12CC(C(=O)OC)=C3NC4=CC=CC=C4[C@@]35CCN(CC=C1)[C@@H]25
InChI
InChIKey=BBASQSWPQOKOQI-OCIDDWSYSA-N
InChI=1S/C21H24N2O2.ClH/c1-3-20-9-6-11-23-12-10-21(19(20)23)15-7-4-5-8-16(15)22-17(21)14(13-20)18(24)25-2;/h4-9,19,22H,3,10-13H2,1-2H3;1H/t19-,20-,21-;/m0./s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. | 2018-08 |
|
| Tabersonine inhibits amyloid fibril formation and cytotoxicity of Aβ(1-42). | 2015-06-17 |
|
| A Cytochrome P-450 Monooxygenase Catalyzes the First Step in the Conversion of Tabersonine to Vindoline in Catharanthus roseus. | 1995-09 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
12443187
Created by
admin on Wed Apr 02 13:39:58 GMT 2025 , Edited by admin on Wed Apr 02 13:39:58 GMT 2025
|
PRIMARY | |||
|
DGR7D6J5TR
Created by
admin on Wed Apr 02 13:39:58 GMT 2025 , Edited by admin on Wed Apr 02 13:39:58 GMT 2025
|
PRIMARY | |||
|
29479-00-3
Created by
admin on Wed Apr 02 13:39:58 GMT 2025 , Edited by admin on Wed Apr 02 13:39:58 GMT 2025
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
